Displaying 1 publication

Abstract:
Sort:
  1. Fulltext Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
    Ranasinghe R, Mathai M, Abdullah Alshawsh M, Zulli A
    Heliyon, 2024 Apr 15;10(7):e28171.
    PMID: 39839154 DOI: 10.1016/j.heliyon.2024.e28171
    AIMS: Cisplatin is a frontline chemotherapeutic utilized to attenuate multiple cancers in the clinic. Given its side-effects, a new cisplatin formulation which could prevent cytotoxicity, metabolic deficiencies and metastasis is much needed. This study investigates whether nanocarriers can provide a better mode of drug delivery in preclinical cancer models seeking a potent anticancer therapeutic agent.

    MATERIALS AND METHODS: The PubMed database was searched, and 242 research articles were screened from which 94 articles qualified for selection from those published by December 31, 2023 and the data was synthesized using the Review Manager software.

    KEY FINDINGS: Cisplatin encapsulated as a nanomedicine confirmed the versatility of nanocarriers in significantly diminishing cancer cell viability, half maximal inhibitory concentration, tumour volume, biodistribution of platinum in tumours and kidney; at p 

Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links